Maintenance immunosuppression and chronic rejection in renal allografts

J. G. Lawen, P. Belitsky

Résultat de recherche: Review articleexamen par les pairs

Résumé

Chronic rejection, the principal cause of late renal allograft failure, has been correlated with multiple factors; one of the more important is adequacy of maintenance immunosuppression. Despite our extensive experience with cyclosporine A (CsA)-based contemporary immunosuppression, the optimal mix of adjunctive agents and the optimal dosage of CsA itself are not yet known. A review of CsA-based double and triple drug protocols, emphasizing maintenance therapy, raised questions about the necessity of steroids in all patients and the routine use of azathioprine in triple therapy. Recent analyses suggest that late graft dysfunction and loss may be related to chronic CsA underdosing; this impression is supported by studies confirming the long-term safety and improved efficacy of higher CsA dosages.

Langue d'origineEnglish
Pages (de-à)98-104
Nombre de pages7
JournalCurrent Opinion in Urology
Volume5
Numéro de publication2
DOI
Statut de publicationPublished - 1995
Publié à l'externeOui

ASJC Scopus Subject Areas

  • Urology

Empreinte numérique

Plonger dans les sujets de recherche 'Maintenance immunosuppression and chronic rejection in renal allografts'. Ensemble, ils forment une empreinte numérique unique.

Citer